In a report released today, Brian Abrahams from RBC Capital maintained a Buy rating on Biogen (BIIB – Research Report), with a price target of ...

The global neuromuscular disease therapeutics market is projected to grow by $13.73 billion between 2025 and 2029, according ...

Truist has initiated coverage of Larimar (LRMR) with a buy rating, citing an "asymmetric" risk/reward ahead of regulatory ...

While the strategic review process is underway, Sage Therapeutics continues to advance its mission of pioneering solutions to ...

Boston Properties (NYSE:BXP) reported its fourth-quarter 2024 earnings, revealing a significant miss on earnings per share ...

It was a busy week for the biotech sector, with regulatory and pipeline updates. Sage Therapeutics SAGE was in focus after it ...

Discover which stocks are splitting, the ratio, and split ex-date with the latest information from EDGAR® Online LLC. Data provided by and © 2024 EDGAR® Online LLC ...

Spotify Technology S.A. 2.24% $100.74B ...

German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 28, 2025. REUTERS/Staff/File Photo World markets were suddenly looking calmer on Wednesday as ...

2-Year U.S. Treasury Note Continuous Contract $102.914 0.027 0.03% 5-Year U.S. Treasury Note Continuous Contract $106.602 0.102 0.10% 10-Year U.S. Treasury Note Continuous Contract $109.203 0.172 ...

Bonus Dec 03, 2024 Dec 03, 2024 Oct 17, 2024 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Mar 06, 2019 Mar 07, 2019 Jan 18, 2019 Bonus Ratio: 1 share(s) for every 3 shares held Bonus Jun 13, ...